Variable | Number (%) | Mean (SD) | Median (IQR) |
---|---|---|---|
Female | 28 (80) | ||
Caucasian | 34 (97) | ||
Age (y) | 62 (10) | 62 (52–68) | |
Married | 30 (86) | ||
Employed | 13 (37) | ||
Graduated high school/attended college | 14 (40) | ||
Graduated college/attended graduate school | 21 (60) | ||
Disease Duration (y) | 21 (11) | 19 (11–32) | |
Medications | |||
Biological DMARDs | 22 (63) | ||
Methotrexate | 18 (51) | ||
TNF inhibitor | 18 (51) | ||
NSAIDs | 12 (34) | ||
Steroids | 14 (40) | ||
Disease markers | |||
Rheumatoid factor >15 | 21 (60) | ||
Anti-CCP positive | 24 (69) | ||
Seropositive | 25 (71) | ||
DAS-CRP3a | 3.2 (1.5) | 2.9 (1.9–4.3) | |
Disease activity (RADAI) | 2.9 (2.1) | 2.3 (1.2–4.7) | |
Self-reported outcomes (PROs) | |||
Multi-dimensional health Assessment Questionnaire (MDHAQ) | 0.62 (0.54) | 0.55 (0.1–1.0) | |
Quality of life (Euroqol Index) | 0.8 (0.2) | 0.8 (0.7–0.8) | |
Mental health score (MHI-5)b | 79 (17.4) | 83 (73–90) | |
Performance Measures | |||
20 m Timed walk (s) | |||
Number of steps | 28 (4.5) | 26 (24.3–30.7) | |
Time taken (seconds) | 16.1 (3.8) | 15.7 (12.9–17.4) | |
Timed Step test (METs)a | 4.7 (0.8) | 4.8 (4.3–5.1) |